REIMBURSEMENT Archives

Pain Management Gets Rewired as Neuromodulation Goes Non-Invasive

16/12/2025by EOS Intelligence

nScientists have been researching the possibility of using electrical impulses to treat many health conditions. The starting point was the introduction of the first TENS (transcutaneous electrical nerve stimulation) device...

China's Medtech Volume-Based Procurement Big Savings, Bigger Challenges by EOS Implicium

China VBP: Turning Down the Volume on MedTech Margins

22/10/2025by EOS Intelligence

China’s phased rollout of Volume-Based Procurement (VBP), which started in the pharmaceutical industry in 2018, quickly expanded to the medical devices market in 2019. VBP standardizes medical device prices in...

MDx Testing Moves Closer to Patients as Labs Lose Their Central Role

10/03/2025by EOS Intelligence

The COVID-19 pandemic brought innovation and investment to the in vitro diagnostics (IVD) market, opening new pathways to simplify and expand testing. The previously complicated and time-consuming molecular testing gradually...

Alzheimer’s Phase 3 Drugs Face High Hopes but Low Success Odds

04/10/2024by EOS Intelligence

Many biopharmaceutical companies, such as AriBio, Annovis Bio, Athira Pharma, Cassava Sciences, and Alzheon, specializing in treating neurodegenerative diseases, are developing drugs for Alzheimer’s disease (AD) that are currently in...

Who We Are

Connect With Us

Work With EOS